Women's Representation in Randomized Controlled Trials Evaluating FDA supervised Medical Devices - A Systematic Review

Published: 27 February 2024| Version 2 | DOI: 10.17632/y5fst3jk4v.2
Contributors:
,

Description

A systematic review of women represetation RCT's evaluating high-risk devices. The Data includes all referenced studies.

Files

Steps to reproduce

Screening for eligible studies and search terms are included in supplements, we used Rayyan software to include appropriate studies, according to the PRISMA guidelines. The participation-to-prevalence ratio (PPR) for devices was calculated as the percentage of women participating / women with the intervention in the general population (See supplement). Categorical data were compared using the Chi-square test, and continuous data was compared using the Mann-Whitney or Kruskal-Wallis tests.

Institutions

Sheba Medical Center at Tel Hashomer, Meir Medical Center, Tel Aviv University

Categories

Medical Device, Equity

Licence